Aclarion, Inc. is a U.S. healthcare technology company that uses magnetic resonance spectroscopy (MRS) with proprietary signal-processing biomarkers to optimize clinical treatments. It develops NOCISCAN, which non-invasively analyzes the chemical makeup of intervertebral discs, and offers the NOCISCAN MRS Exam Protocol, a software protocol for using MRS pulse sequences in disc scanning. The company also provides imaging data transfer products, including AMBRA Healthcare, and the NOCISCAN Post-Processor Suite, which includes NOCICALC and NOCIGRAM. Formerly Nocimed, Inc., it changed its name to Aclarion, Inc. in December 2021, was incorporated in 2008, and is based in Broomfield, Colorado.